It should be safety-first on stem cell therapies
By Editorial,
The Boston Globe
| 02. 12. 2016
Untitled Document
As interest in alternative medicines has risen, so has the number of clinics pushing the supposed benefits of stem cell therapies. These businesses say stem cells have the power to help the body repair itself, without surgery or painful side effects. They’re using them to treat everything from cosmetic “flaws” (sagging skin and hair loss) to life-changing ailments (Parkinson’s disease and diabetes). The clinics’ pitches are carefully crafted to hype potentially dramatic results, without running afoul of federal regulators. A “rejuvenation center” in Arizona sells a treatment that will “improve your marriage.” A Florida stem cell company advertises “groundbreaking advances” that give patients “the ability to fight back against diseases once thought untreatable.” And a California outfit claims its customers have reported “higher energy levels, better sleep, and overall improved quality of life.”
It all sounds appealing, maybe even borderline miraculous, but the safety and effectiveness of such services is, at best, questionable. Until now, stem cell clinics have faced only minimal scrutiny from the Food and Drug Administration. Unlike drugs and medical devices, stem cell...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
By Julie Métraux, Mother Jones | 09.23.2025